Waterway Wealth Management LLC Purchases Shares of 2,279 Axon Enterprise, Inc $AXON

Waterway Wealth Management LLC acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 2,279 shares of the biotechnology company’s stock, valued at approximately $968,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Legal & General Group Plc raised its holdings in shares of Axon Enterprise by 1.3% in the 4th quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after buying an additional 5,419 shares in the last quarter. Eurizon Capital SGR S.p.A. bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $13,116,000. Wealth Enhancement Advisory Services LLC boosted its stake in Axon Enterprise by 93.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock valued at $13,270,000 after buying an additional 11,262 shares in the last quarter. Teamwork Financial Advisors LLC boosted its stake in Axon Enterprise by 40.5% in the 4th quarter. Teamwork Financial Advisors LLC now owns 25,352 shares of the biotechnology company’s stock valued at $14,398,000 after buying an additional 7,307 shares in the last quarter. Finally, Clearbridge Investments LLC grew its position in Axon Enterprise by 21.1% in the fourth quarter. Clearbridge Investments LLC now owns 343,910 shares of the biotechnology company’s stock valued at $195,317,000 after acquiring an additional 59,821 shares during the period. 79.08% of the stock is owned by institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 564 shares of Axon Enterprise stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $478.97, for a total value of $270,139.08. Following the completion of the transaction, the director directly owned 3,632 shares of the company’s stock, valued at $1,739,619.04. The trade was a 13.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the transaction, the insider owned 34,024 shares in the company, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 38,989 shares of company stock valued at $19,090,083. 4.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have issued reports on AXON. Citizens Jmp reiterated a “market outperform” rating and set a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. The Goldman Sachs Group set a $535.00 target price on shares of Axon Enterprise in a research report on Thursday, May 7th. Finally, Piper Sandler reissued an “overweight” rating and set a $674.00 price target on shares of Axon Enterprise in a report on Monday, June 15th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $712.75.

Axon Enterprise Stock Down 2.6%

Shares of AXON opened at $444.73 on Friday. The company has a market capitalization of $35.85 billion, a P/E ratio of 178.61, a PEG ratio of 8.30 and a beta of 1.45. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The business’s 50 day simple moving average is $419.39 and its 200-day simple moving average is $482.20. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. During the same period last year, the firm posted $1.47 EPS. The business’s revenue was up 33.7% on a year-over-year basis. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Citizens JMP reaffirmed its Market Outperform rating on Axon and kept a $700 price target, implying meaningful upside from current levels as adoption of AI, 911 dispatch tools, and drone technology accelerates across U.S. agencies. Benzinga article
• Positive Sentiment: Coverage around Dedrone highlighted expanding counter-drone capabilities, with the business reportedly generating more bookings than its acquisition price, reinforcing the view that Axon’s platform expansion is creating real revenue momentum. Axon stock trades up article
• Positive Sentiment: Multiple articles framed Axon as a beneficiary of rising demand for AI-powered public safety tools, including body cameras, software, dispatch, and drone-related products, which supports the long-term growth narrative for AXON. TipRanks article
• Neutral Sentiment: Axon was also noted as a trending stock on Zacks and in broader industry outlook pieces, which reflects heightened investor attention but does not by itself change fundamentals. Zacks trending stock article
• Neutral Sentiment: A report on short interest showed effectively no active short positioning, so it does not appear to be a meaningful driver of the stock right now.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.